TORISEL
Google image searchProduct monograph
Active ingredient
temsirolimus, 25 MG/ML
DIN: 02304104
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 11-JUL-2011
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EG — Mammalian target of rapamycin (mTOR) kinase inhibitors (ATC, ATC/DDD)
- L01EG01 — TEMSIROLIMUS (ATC/DDD)
Reference brand drug: Torisel
Pharmaceutical standard: MFR
